Zobrazeno 1 - 6
of 6
pro vyhledávání: '"John C. Kunich"'
Autor:
Richard L. Lester, John C. Kunich
Publikováno v:
Journal of Leadership Studies. 6:17-35
Executive Summary Mentoring is both an opportunity and a risk. It is largely a teaching process beginning with parental nurturing of children and continuing through the lifecycle of organizational and personal interrelationships. A key principle cons
Autor:
John C. Kunich, Haynes W. Sheppard, Susan E. Wilson, Victoria L. Wilkins, Shannon L. Pedersen, James Tartaglia, Gail P. Mazzara, Dean L. Mann, Connie Celum
Publikováno v:
AIDS Research and Human Retroviruses. 14:925-937
A major objective of current HIV-1 vaccination strategies is the induction of HIV-1-specific CD8+ MHC class I-restricted CTL responses, which are suggested to play a pivotal role in viral clearance and protection against HIV-1 disease progression. Ho
Autor:
Richard I. Lester, John C. Kunich
Publikováno v:
Journal of Leadership Studies. 4:17-32
Many organizations of all types have attempted to jump on the Quality bandwagon, with widely varying results. One reason why some Quality programs fail is that the leaders and managers within the organization do not fully understand the interdependen
Autor:
John C. Kunich, Richard I. Lester
Publikováno v:
Journal of Leadership Studies. 4:5-18
This is a study of the leadership principles employed by Raoul Wallenberg, a Swedish diplomat who went to Budapest in 1944 to intervene on behalf of Hungary's 700,000 Jews who were being deported by the Nazis to extermination camps. This extended cas
Autor:
Richard I. Lester, John C. Kunich
Publikováno v:
Journal of Leadership Studies. 3:3-22
One of the key proficiencies a good leader must possess is the art of giving and receiving feedback. All of the other tools of leadership combined will not allow anyone to be fully effective if feedback is lacking. The vision; talents, and competenci
Autor:
John C. Kunich, Lawrence S. Cousens, Yan Tang, Evelyn N. Garrett, Carla Heise, Daniel Menezes, Bahija Jallal, Arnold B. Gelb, Sharon Lea Aukerman, Susan E. Wilson, Kimberly Denis-Mize, Helen Ye, Jing Peng
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 30(1)
Recombinant interleukin-2 (rIL-2) is a pleiotropic cytokine that activates select immune effector cell responses associated with antitumor activity, including antibody-dependent cellular cytotoxicity (ADCC). Rituximab is an anti-CD20 monoclonal antib